AstraZeneca (AZN) announced an update on their ongoing clinical study. Study Overview AstraZeneca is running a Phase IIb study titled “A Phase IIb, Randomized, Double-blind, Placebo-controlled Study ...
In a review of nearly 120,000 patients, 31% taking opioids developed C. diff, compared to 17% not taking them Opioids may weaken immunity and disrupt healthy gut bacteria, making infection more likely ...
Opioid Use Linked to Higher Risk of C. Diff Infection, Study Finds WEDNESDAY, Dec. 10, 2025 (HealthDay News) — Taking opioids may make some patients more likely to develop a dangerous infection, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback